CEACAM5 and pancreatic neoplasm: In another example of theranostics, Maawy et al. used a chimeric anti-CEA antibody conjugated with IRDye 700DX NHS Ester to perform PIT in mice with BxPC3 orthotopic pancreatic cancer [54].